Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib with Docetaxel and Carboplatin in Newly Diagnosed Ovarian Cancer
NCT00217529Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jun 2004
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in ovarian epithelial cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC), sponsored by Fred Hutchinson Cancer Center. Started Jun 2004; status: completed.
02
Drugs
erlotinib
03
Conditions
ovarian epithelial cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT00217529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00217529.